A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer (DFU) Interventions: Biological: APO-2; Other: Placebo Sponsors: Aposcience AG; FGK Clinical Research GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials